We are live on ! Find out more
GKIM

GW&K Investment Management Portfolio holdings

AUM $12.8B
1-Year Est. Return 48.82%
This Fund
S&P 500
This Quarter Est. Return
+3.15%
1 Year Est. Return
+48.82%
3 Year Est. Return
+110.09%
5 Year Est. Return
+134.03%
10 Year Est. Return
+612.52%
AUM
$11.8B
AUM Growth
+$76M
Cap. Flow
-$34.6M
Cap. Flow %
-0.29%
Top 10 Hldgs %
11.39%
Holding
986
New
26
Increased
388
Reduced
338
Closed
13

Top Buys

Rank Stock Value
1
CFR icon
Cullen/Frost Bankers
CFR
+$45.7M
2
MEDP icon
Medpace
MEDP
+$45.2M
3
AIZ icon
Assurant
AIZ
+$29.9M
4
EPAC icon
Enerpac Tool Group
EPAC
+$23.9M
5
TILE icon
Interface
TILE
+$23.6M

Top Sells

Rank Stock Value
1
NSIT icon
Insight Enterprises
NSIT
+$29.6M
2
MANH icon
Manhattan Associates
MANH
+$23M
3
SYY icon
Sysco
SYY
+$21.4M
4
FIX icon
Comfort Systems
FIX
+$21.2M
5
PIPR icon
Piper Sandler
PIPR
+$19.7M

Sector Composition

Rank Sector Weight
1 Industrials 17.91%
2 Technology 17.69%
3 Healthcare 16.96%
4 Financials 14.09%
5 Consumer Discretionary 12.43%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
NVO
451
Novo Nordisk
NVO
$203B
$59K ﹤0.01%
681
+250
+58% +$27K
SCHC icon
452
Schwab International Small-Cap Equity ETF
SCHC
$5.67B
$59K ﹤0.01%
1,726
+1,377
+395% +$50.2K
TFC icon
453
Truist Financial
TFC
$64.3B
$59K ﹤0.01%
1,360
+12
+0.9% +$536
AZO icon
454
AutoZone
AZO
$49.7B
$58K ﹤0.01%
18
+10
+125% +$31.7K
GILD icon
455
Gilead Sciences
GILD
$168B
$58K ﹤0.01%
628
+36
+6% +$3.24K
NOC icon
456
Northrop Grumman
NOC
$82B
$58K ﹤0.01%
124
-4
-3% -$2.01K
SBUX icon
457
Starbucks
SBUX
$124B
$58K ﹤0.01%
632
+4
+0.6% +$387
WEC icon
458
WEC Energy
WEC
$35.6B
$58K ﹤0.01%
620
+1
+0.2% +$97
GEV icon
459
GE Vernova
GEV
$277B
$58K ﹤0.01%
176
+4
+2% +$1.25K
ADI icon
460
Analog Devices
ADI
$187B
$57K ﹤0.01%
269
IEMG icon
461
iShares Core MSCI Emerging Markets ETF
IEMG
$158B
$57K ﹤0.01%
1,094
CSX icon
462
CSX Corp
CSX
$92.8B
$56K ﹤0.01%
1,748
-5
-0.3% -$171
GSK icon
463
GSK
GSK
$101B
$56K ﹤0.01%
1,645
MO icon
464
Altria Group
MO
$107B
$56K ﹤0.01%
1,065
+38
+4% +$2.02K
SM icon
465
SM Energy
SM
$7.71B
$56K ﹤0.01%
1,456
-355
-20% -$15K
VRTX icon
466
Vertex Pharmaceuticals
VRTX
$133B
$53K ﹤0.01%
132
-1
-0.8% -$464
ADP icon
467
Automatic Data Processing
ADP
$107B
$52K ﹤0.01%
176
+2
+1% +$591
LULU icon
468
lululemon athletica
LULU
$13.7B
$52K ﹤0.01%
136
+5
+4% +$1.63K
SLB icon
469
SLB Ltd
SLB
$78.1B
$52K ﹤0.01%
1,350
-122
-8% -$5.12K
EQIX icon
470
Equinix
EQIX
$105B
$51K ﹤0.01%
54
ITW icon
471
Illinois Tool Works
ITW
$83.3B
$51K ﹤0.01%
202
+6
+3% +$1.59K
PLD icon
472
Prologis
PLD
$134B
$51K ﹤0.01%
479
-56
-10% -$6.44K
RTO icon
473
Rentokil
RTO
$12.3B
$51K ﹤0.01%
2,004
SHEL icon
474
Shell
SHEL
$249B
$51K ﹤0.01%
815
D icon
475
Dominion Energy
D
$59.8B
$50K ﹤0.01%
931
+26
+3% +$1.48K

Similar funds

GW&K Investment Management's Q4 2024 Portfolio in Review

As of Q4 2024, GW&K Investment Management held 986 positions worth $11.8B, up 0.65% from $11.7B the previous quarter. Its ten largest holdings account for 11% of the portfolio.

Trading was light in Q4 2024: portfolio turnover was 4%. GW&K Investment Management opened 26 new positions and exited 13, leaving the 986-position portfolio largely intact.

By sector, the portfolio is most concentrated in Industrials at 18% of assets, down from 18% a quarter earlier, followed by Technology and Healthcare.

  • GW&K Investment Management's largest Q4 2024 buy was Cullen/Frost Bankers: 347,838 shares worth $46.7M.
  • GW&K Investment Management added most to Medpace in Q4 2024, an estimated $45.2M increase.
  • GW&K Investment Management's biggest Q4 2024 reduction was Insight Enterprises, cutting an estimated $29.6M.
  • GW&K Investment Management fully exited Insperity in Q4 2024, selling an estimated $8.17M.
  • GW&K Investment Management's ten largest holdings make up 11% of its $11.8B portfolio in Q4 2024.
  • GW&K Investment Management opened 26 new positions and closed 13 in Q4 2024.
  • GW&K Investment Management's portfolio value rose 0.65% quarter-over-quarter to $11.8B.

Based on GW&K Investment Management's 13F filing for Q4 2024, filed 5 Feb 2025.